
Best mid-cap healthcare stocks to invest in 2026
Mid-cap healthcare blends innovation with scalability, offering investors exposure to diverse medical advances. These companies expand access, improve outcomes, and compound growth through focused execution. Krystal Biotech develops gene therapies for rare skin diseases, led by its FDA-approved Vyjuvek treatment for dystrophic epidermolysis bullosa patients. UFP Technologies is a leading designer and producer of custom-engineered components using foams, films, and advanced materials for diverse industries. Hims & Hers Health is a direct-to-consumer telehealth company offering personalized virtual care, prescriptions, and over-the-counter products through a comprehensive digital platform. These mid-cap healthcare leaders combine disciplined execution with durable growth potential. These are among the best mid-cap healthcare stocks for 2026.
Tags: stocks







